pmunch
3 days ago
RLAB News: Another Great New board member
https://www.accesswire.com/856119/rlab-m2mma-welcomes-legendary-triathlete-chris-mccormack-to-advisory-board
DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / April 24, 2024 / Real American Capital Corp (RLAB), trading as M2MMA, is proud to announce the appointment of Chris McCormack, also known as "Macca," to its Advisory Board. McCormack, globally celebrated for his extraordinary achievements in endurance sports, brings a storied triathlon career and profound business acumen to M2MMA.
Chris McCormack's career highlights include more than 200 international race victories and an impressive record of 76% podium finishes since 1993. He has dominated as the #1 ITU Triathlete globally for 243 weeks, achieved 16 Ironman victories, and won the Ironman World Championships twice. His accolades include being a five-time International Triathlete of the Year and breaking the eight-hour mark in Ironman distance races four times.
After completing his studies in Business and Accounting at The University of NSW, McCormack was fully committed to the triathlon and quickly rose to international prominence. His business ventures are equally impressive, including establishing the MINC Group, which later became MANA Sports and Entertainment, and founding SuperTri, now known as Super League Triathlon. Additionally, McCormack has worked as a chief consultant for sports for the Royal Family of Bahrain and launched the global Pho3nix Foundation for Sports, significantly impacting the sports landscape.
Moreover, Chris McCormack's entrepreneurial spirit is demonstrated by establishing the Thanyapura Sports Resort in Phuket, Thailand - a $250 million project that has become a world-renowned sports facility. His involvement as a chief consultant for the Royal Family of Bahrain led to the creation of the Tour de France team Bahrain Victorious and the triathlon team Bahrain Victorious 13, further cementing his influence in global sports management.
Chris McCormack said, "Joining the M2MMA Advisory Board allows me to bring my extensive experience from endurance sports into the innovative and dynamic world of professional mixed martial arts. My career has been about embracing challenges and striving for excellence, which I eagerly anticipate bringing to M2MMA."
jdcpa1
1 month ago
It's Game on for MRES and RLAB imo... Sleeping giants and this is only one division of MRES which majority owns and controls RLAB.
"Jeff's Corner: 🪑This Sunday, March 31, in Phuket, Thailand, we will unveil M2MMA1, 🥊🥋 a concept that evolved from dream to reality in six months. This significant event is the first step towards our broader mission to unify and uplift the fragmented Muay Thai community, starting in Phuket and then advancing through Bangkok, Singapore, Asia, and Australia🇹🇭🇸🇬🇦🇦🇺
My ambition for M2MMA transcends traditional Mixed Martial Arts promotions. One of my/our many goals is to build a USD 3 billion enterprise within five years (why 3 billion, it's doable), coupling exhilarating sports with cutting-edge proprietary Big Data and AI technology. This approach is not solely for the sport’s enhancement but is pivotal for gathering critical health data to benefit the global community. Specifically, CTE- Chronic Traumatic Encephalopathy, CTE, is a progressive degenerative disease affecting people who have suffered repeated concussions and traumatic brain injuries that may occur in some athletes and others who have been exposed to concussions and repetitive head impacts.🧠
The upcoming M2MMA Stadium and training facility, The Jungle, 🌴near Phuket’s airport, will be the hub for this innovative mission and provide a foundation for our plans to revolutionize the martial arts sector globally.
Moreover, a core part of our mission is to revolutionize athlete care in the sport. We are committed to providing unprecedented pre-, post, and long-term healthcare for our M2MMA athletes. This initiative ensures their well-being inside and outside the ring, setting new standards in athlete care and support in combat sports. Our holistic approach to athlete welfare will include state-of-the-art medical support, rehabilitation services, and long-term health monitoring, ensuring our fighters receive the highest standard of care, making M2MMA a pioneering force in sports health and entertainment.
I'm pumped; I hope you are as well. 💪❤️
#GoBigorGoHome #peakperformance"
jdcpa1
3 months ago
M2MMA Announces 2024 Fight Schedule and Appoints CEOPress Release | 10/12/2023
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / October 12, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alternative plant-based cannabinoids, medical psilocybin, and cutting-edge mental health therapeutic research driven by artificial intelligence (AI), is pleased to announce the following update with its M2MMA division:
M2MMA, the latest division of M2BIO Sciences, has officially confirmed its first two promotional events, which will take place in the picturesque setting of Phuket, Thailand. The first event is scheduled for late March 2024 at the iconic Sinbi Boxing Stadium, followed by the second in late May 2024. These promotions will feature undercard and main card events, offering a thrilling combination of Muay Thai and MMA, all sanctioned by the esteemed World Muay Thai Organisation (WMO).
M2MMA is strategically aligning itself with the 6th International and Thai Martial Arts Games (ITMA Games), which host a wide range of martial arts competitions, including Muay Thai, kickboxing, boxing, karate, BJJ, dap thai (Thai sword), muay boran, and amateur MMA, all sanctioned by renowned international martial arts organizations. The ITMA Games will be held at Saphan Hin Stadium two weeks before M2MMA's first promotional event in March. Martial arts enthusiasts mark your calendars, as March promises to be a month filled with exciting action.
Following the thrilling bouts in Thailand, M2MMA will host its next set in Pretoria, South Africa, with events scheduled for late July and September. The season finale will unfold in the dazzling city of Dubai in October and November.
"I am thrilled to see this come to fruition and to witness M2MMA excel in combat sports. As the executive assistant for the ITMA Games and the WMO, I extend my full support and gratitude to M2MMA for allowing me to be part of this revolutionary mixed martial arts organization." - Jade Sirisompan.
M2MMA is not just another player in the world of MMA; it is an innovative and disruptive division of M2BIO with a clear vision to revolutionize the world of mixed martial arts (MMA) by placing their athletes' well-being and long-term health at the forefront. Jeff Robinson, the visionary behind M2MMA, states, "We are committed to transforming the industry standard by pioneering a new era of fighter care that extends far beyond the ring."
M2MMA will also introduce the use of Artificial Intelligence (AI) in a groundbreaking fashion. Robinson says, "We are going to go ballistic." With this technology, viewers will have access to real-time data and metrics, offering unprecedented insight into the action inside the ring. You'll be able to see the real-time physiological condition of each athlete, the force of each blow, the impact of each strike, and so much more.
In addition, M2BIO Sciences proudly announces the appointment of Victor Lange as CEO of M2MMA. Lange, with a rich history in the world of sports, including studying in the US and earning his playing rights on the PGA Tour for several years, has since been deeply involved in the fitness and business world. Lange is enthusiastic about his role and affirms, "I'm unbelievably proud and honored to lead M2BIO's revolutionary new M2MMA division. Our fights will be exclusive, our fighters will receive the best treatment, and we will entertain viewers like never before. MMA is a sport that includes high-level problem-solving with dire physical consequences. M2MMA will provide the means and care to showcase that to its fullest potential.''
For comprehensive insights into our company and our foray into fitness innovation, M2BIO Sciences cordially invites you to explore our official website. Watch for forthcoming events and disclosures as we navigate this groundbreaking fusion of MMA and the scientific realm. M2MMA's commitment to athlete welfare, technological innovation, and global expansion promises an exciting future for both fighters and fans of mixed martial arts.
About Institute of Biomedical Research Corp./ DBA M2Bio Sciences
Institute of Biomedical Research Corp is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx, Medspresso, Liviana brands as well as artificial intelligence-powered nutrition products and solutions under the M2Biome brand. In addition, our research and clinical trials with psilocybin are aimed at new therapies to help patients suffering from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies such as artificial intelligence.
The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "MRES".
Publicly traded Company (OTC Pink: MRES)
www.m2bio.co
jeff@m2bio.co
+27 72 333 2148
Find M2Bio on social media
Facebook:M2Bio
Instagram:M2bio.Sciences
LinkedIn:M2Bio
Twitter:@M2bio
Forward-Looking Statements
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences to include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE: Institute of BioMedical Research Corp.
View source version on accesswire.com:
https://www.accesswire.com/792324/m2mma-announces-2024-fight-schedule-and-appoints-ceo
jdcpa1
3 months ago
Real American Announces Acquisition of M2MMA from MRES
01/30/24 9:30 AM
PALM SPRINGS, CA / ACCESSWIRE / January 30, 2024 / The Real American Capital Corporation (OTC PINK:RLAB) is pleased to announce the acquisition from Institute of Biomedical Research Corporation (OTC PINK:MRES) 100% ownership of the concept, business model, contacts and contracts that collectively can be used to establish a mixed martial arts league and are herein referred to as "M2MMA" (https://m2mma.com).
The transaction will be settled entirely in shares, resulting in a change of control of Real American Capital Corporation.
It was previously announced that Jeff Robinson and Willem Jonker, CEO and CFO of MRES, respectively, have been appointed Chairman and Chief Financial Officer of RLAB.
Doug Newton, outgoing co-CEO of RLAB and a black belt holder, has a lifelong connection to martial arts and the world of professional sports. "M2MMA is just the right business for the Company, especially with the exciting innovations Jeff and his team are bringing to the sport", he says.
"The M2MMA concept, which will revolutionize mixed martial arts, was incubated inside MRES over the past months and is now ready to be spun out and stand on its own feet. You can expect many more details to be revealed very soon", says Jeff Robinson.
About Real American Capital Corp. (OTC PINK: RLAB):
Real American Capital Corporation (OTC PINK: RLAB) trades on the Pink Open Market. Investors can find Real-Time quotes and market information for the company at https://www.otcmarkets.com/stock/RLAB/.
RLAB's menu of US trademarks registered or applied for includes Resurgent®; Nature Treating Nature®; Born & Bred in the USA® (owned by RLAB since 2011); Rising Harvest; and Healthy Living Soil ®.
Forward-Looking Statement:
This release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These statements appear in several places in this release and include all statements that are not statements of historical fact regarding the intent, belief, or current expectations of Real American Capital Corp., its directors, or its officers concerning, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy.
Contact:
Jeff Robinson, CEO
Jeff@m2bio.co
+27 72 333 2148
Real American Capital Corp. 74725 Joni Drive -- Palm Desert, CA 92260
Real American Capital Corporation
About Institute of Biomedical Research Corp./ DBA M2Bio Sciences
Institute of Biomedical Research Corp., trading as M2Bio Sciences, is a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research. M2Bio's mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies.
M2Bio conducts research at the M2Bio Discovery Centre for AI-Driven Phytomedicine Research at the University of Pretoria in South Africa. The research aims to provide scientific backing for the Company's expanding product range - including plant-based medicines.
The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "MRES". Publicly traded Company (OTC Pink: MRES)
Contact:
www.m2bio.co
jeff@m2bio.co
+27 72 333 2148
SOURCE: Real American Capital Corporation
View the original press release on accesswire.com
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
SkyTrader7
1 month ago
Lottalead
2 months ago
LowFloatLopes
3 months ago
Zardiw
3 months ago
gail
3 months ago
Hot Features
Premium
